462 related articles for article (PubMed ID: 33640783)
1. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
[TBL] [Abstract][Full Text] [Related]
2. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
[TBL] [Abstract][Full Text] [Related]
3. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
Nisar T; Hanumanthu R; Khandelwal P
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
[TBL] [Abstract][Full Text] [Related]
6. Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.
Kamal H; Mehta BK; Ahmed MK; Kavak KS; Zha A; Lail NS; Shirani P; Al-Mufti F; Sawyer RN; Mowla A
J Neurol Sci; 2021 Jan; 420():117265. PubMed ID: 33333324
[TBL] [Abstract][Full Text] [Related]
7. Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis.
Kurowski D; Jonczak K; Shah Q; Yaghi S; Marshall RS; Ahmad H; McKinney J; Torres J; Ishida K; Cucchiara B
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1104-1109. PubMed ID: 28110890
[TBL] [Abstract][Full Text] [Related]
8. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
[TBL] [Abstract][Full Text] [Related]
9. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
You S; Saxena A; Wang X; Tan W; Han Q; Cao Y; Liu CF
Stroke Vasc Neurol; 2018 Mar; 3(1):22-27. PubMed ID: 29600004
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy.
Abbas A; Hamad AA; El Din Moawad MH; Ewis DK; Youssef RA; Hamouda H; Hassan MA; Aladawi M; Elfil M; Meshref M; Al-Mufti F
J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107704. PubMed ID: 38561167
[TBL] [Abstract][Full Text] [Related]
14. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
[TBL] [Abstract][Full Text] [Related]
15. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke.
Mowla A; Sharifian-Dorche M; Mehla S; Lail NS; Sharifian-Dorche A; Vaughn CB; Sawyer RN; Shirani P
J Neurol Sci; 2021 Jun; 425():117451. PubMed ID: 33882341
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Stroke-Associated Infection and other Readily Available Parameters in Acute Ischemic Stroke Treated by Intravenous Thrombolysis.
Derbisz J; Nowak K; Wnuk M; Pulyk R; Jagiella J; Slowik J; Dziedzic T; Slowik A
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105525. PubMed ID: 33338755
[TBL] [Abstract][Full Text] [Related]
18. Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial.
Adeoye O; Sucharew H; Khoury J; Vagal A; Schmit PA; Ewing I; Levine SR; Demel S; Eckerle B; Katz B; Kleindorfer D; Stettler B; Woo D; Khatri P; Broderick JP; Pancioli AM
Stroke; 2015 Sep; 46(9):2529-33. PubMed ID: 26243231
[TBL] [Abstract][Full Text] [Related]
19. Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.
Wong JWP; Churilov L; Dowling R; Mitchell P; Bush S; Kanesan L; Yan B
Cerebrovasc Dis; 2018; 46(5-6):193-199. PubMed ID: 30384367
[TBL] [Abstract][Full Text] [Related]
20. Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.
Lee VH; Conners JJ; Cutting S; Song SY; Bernstein RA; Prabhakaran S
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2139-2144. PubMed ID: 25081309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
